C-MER Eye
Providing ophthalmic, general medical and surgical services.
Launch date
Market cap
€281m
Enterprise valuation
€259m (Public information from Sep 2024)
Share price
HKD2.17 3309.HK
Hong Kong Island Hong Kong (HQ)
Financials
Estimates*
HKD | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Revenues | 576m | 700m | 1.1b | 1.7b | 1.9b |
% growth | - | 21 % | 59 % | 56 % | 11 % |
EBITDA | 139m | 123m | 176m | 266m | 366m |
% EBITDA margin | 24 % | 18 % | 16 % | 15 % | 19 % |
Profit | 41.4m | (6.2m) | 21.9m | (21.9m) | 62.0m |
% profit margin | 7 % | (1 %) | 2 % | (1 %) | 3 % |
Date | Investors | Amount | Round |
---|---|---|---|
N/A | N/A | IPO | |
* | N/A | HKD388m | Private Placement VC |
Total Funding | €42.6m |
Recent News about C-MER Eye
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by C-MER Eye
EditACQUISITION by Alcon May 2024